{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:28Z","timestamp":1790890348767,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22074024"],"award-info":[{"award-number":["22074024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["21005022"],"award-info":[{"award-number":["21005022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2022A1515012045"],"award-info":[{"award-number":["2022A1515012045"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03246-z","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:11:18Z","timestamp":1753521078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between taurine transporter SLC6A6 and breast cancer development and prognosis: a Mendelian randomization analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Xinping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"3246_CR1","unstructured":"Menon G, Alkabban FM, Ferguson T, Cancer B. StatPearls Publishing Copyright \u00a9 2024, Treasure Island (FL) (2024)."},{"key":"3246_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, CA. Cancer J Clin. 2024;74:12\u201349.","journal-title":"Cancer J Clin"},{"key":"3246_CR3","doi-asserted-by":"publisher","first-page":"991183","DOI":"10.3389\/fsoc.2022.991183","volume":"7","author":"K Bright","year":"2022","unstructured":"Bright K. Understanding system barriers and facilitators in transnational clinical cancer research: the value of rapid and multimodal ethnographic inquiry. Front Sociol. 2022;7:991183.","journal-title":"Front Sociol"},{"key":"3246_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction, Semin. Cancer Biol. 2021;72:238\u201350.","journal-title":"Cancer Biol"},{"key":"3246_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.5551\/jat.RV17036","volume":"26","author":"M Iida","year":"2019","unstructured":"Iida M, Harada S, Takebayashi T. Application of metabolomics to epidemiological studies of atherosclerosis and cardiovascular disease. J Atheroscler Thromb. 2019;26:747\u201357.","journal-title":"J Atheroscler Thromb"},{"key":"3246_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijbs.23082","volume":"14","author":"B Li","year":"2018","unstructured":"Li B, Lu X, Wang J, He X, Gu Q, Wang L, Yang Y. The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR-\/- mice. Int J Biol Sci. 2018;14:36\u201346.","journal-title":"Int J Biol Sci"},{"key":"3246_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology, CA. Cancer J Clin. 2021;71:333\u201358.","journal-title":"Cancer J Clin"},{"key":"3246_CR8","first-page":"e1795","volume":"6","author":"GS Suri","year":"2023","unstructured":"Suri GS, Kaur G, Carbone GM, Shinde D. Metabolomics in oncology. Cancer Rep (Hoboken). 2023;6:e1795.","journal-title":"Cancer Rep (Hoboken)"},{"key":"3246_CR9","doi-asserted-by":"publisher","first-page":"19522","DOI":"10.18632\/oncotarget.14521","volume":"8","author":"M Jov\u00e9","year":"2017","unstructured":"Jov\u00e9 M, Collado R, Quiles JL, Ram\u00edrez-Tortosa MC, Sol J, Ruiz-Sanjuan M, et al. A plasma metabolomic signature discloses human breast cancer. Oncotarget. 2017;8:19522\u201333.","journal-title":"Oncotarget"},{"key":"3246_CR10","doi-asserted-by":"publisher","first-page":"104156","DOI":"10.1016\/j.critrevonc.2023.104156","volume":"192","author":"N Jan","year":"2023","unstructured":"Jan N, Sofi S, Qayoom H, Haq BU, Shabir A, Mir MA. Targeting breast cancer stem cells through retinoids: A new hope for treatment. Crit Rev Oncol Hematol. 2023;192:104156.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3246_CR11","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago VM, Alvarado LZ, Shanaiah N, Gowda GA, Owusu-Sarfo K, Ballas RA, et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 2010;70:8309\u201318.","journal-title":"Cancer Res"},{"key":"3246_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1039\/D1MO00387A","volume":"18","author":"Y Liu","year":"2022","unstructured":"Liu Y, Qi C, Zheng L, Li J, Wang L, Yang Y. 1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer. Mol Omics. 2022;18:167\u201377.","journal-title":"Mol Omics"},{"key":"3246_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3892\/ijo.2020.5100","volume":"57","author":"S Baliou","year":"2020","unstructured":"Baliou S, Kyriakopoulos AM, Spandidos DA, Zoumpourlis V. Role of taurine, its haloamines and its LncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review). Int J Oncol. 2020;57:631\u201364.","journal-title":"Int J Oncol"},{"key":"3246_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-016-0289-9","volume":"8","author":"S Huang","year":"2016","unstructured":"Huang S, Chong N, Lewis NE, Jia W, Xie G, Garmire LX. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis. Genome Med. 2016;8:34.","journal-title":"Genome Med"},{"key":"3246_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00726-018-2650-3","volume":"50","author":"RA Ribeiro","year":"2018","unstructured":"Ribeiro RA, Bonfleur ML, Batista TM, Borck PC, Carneiro EM. Regulation of glucose and lipid metabolism by the pancreatic and extra-pancreatic actions of taurine. Amino Acids. 2018;50:1511\u201324.","journal-title":"Amino Acids"},{"key":"3246_CR16","doi-asserted-by":"publisher","first-page":"173533","DOI":"10.1016\/j.ejphar.2020.173533","volume":"885","author":"L Guan","year":"2020","unstructured":"Guan L, Miao P. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. Eur J Pharmacol. 2020;885:173533.","journal-title":"Eur J Pharmacol"},{"key":"3246_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10456-011-9215-3","volume":"14","author":"IM El Agouza","year":"2011","unstructured":"El Agouza IM, Eissa SS, El Houseini MM, El-Nashar DE. Abd El hameed, taurine: a novel tumor marker for enhanced detection of breast cancer among female patients. Angiogenesis. 2011;14:321\u201330.","journal-title":"Angiogenesis"},{"key":"3246_CR18","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1007\/s11033-013-2691-3","volume":"40","author":"A Hasim","year":"2013","unstructured":"Hasim A, Aili A, Maimaiti A, Mamtimin B, Abudula A, Upur H. Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Mol Biol Rep. 2013;40:5853\u20139.","journal-title":"Mol Biol Rep"},{"key":"3246_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.6026\/97320630013202","volume":"13","author":"N Kumar","year":"2017","unstructured":"Kumar N, Shahjaman M, Mollah MNH, Islam SMS. Hoque, serum and plasma metabolomic biomarkers for lung Cancer. Bioinformation. 2017;13:202\u20138.","journal-title":"Bioinformation"},{"key":"3246_CR20","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1021\/pr900524z","volume":"8","author":"X Zhang","year":"2009","unstructured":"Zhang X, Wang Y, Hao F, Zhou X, Han X, Tang H, et al. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res. 2009;8:5188\u201395.","journal-title":"J Proteome Res"},{"key":"3246_CR21","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1038\/s41598-018-27538-3","volume":"8","author":"A Loras","year":"2018","unstructured":"Loras A, Trassierra M, Sanjuan-Herr\u00e1ez D, Mart\u00ednez-Bisbal MC, Castell JV, Quint\u00e1s G, et al. Bladder cancer recurrence surveillance by urine metabolomics analysis. Sci Rep. 2018;8:9172.","journal-title":"Sci Rep"},{"key":"3246_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nbm.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter B, Bathen TF, Singstad TE, Fj\u00f8sne HE, Lundgren S, Halgunset J, et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed. 2010;23:424\u201331.","journal-title":"NMR Biomed"},{"key":"3246_CR23","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.2174\/0929867325666180629123817","volume":"26","author":"G Bj\u00f8rklund","year":"2019","unstructured":"Bj\u00f8rklund G, Dadar M, Aaseth J, Chirumbolo S, Pen JJ. Cancer-associated cachexia, reactive oxygen species and nutrition therapy. Curr Med Chem. 2019;26:5728\u201344.","journal-title":"Curr Med Chem"},{"key":"3246_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","volume":"136","author":"J Luo","year":"2009","unstructured":"Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136:823\u201337.","journal-title":"Cell"},{"key":"3246_CR25","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.3390\/molecules26164913","volume":"26","author":"CJ Jong","year":"2021","unstructured":"Jong CJ, Sandal P, Schaffer SW. The role of taurine in mitochondria health: more than just an antioxidant. Molecules. 2021;26:4913.","journal-title":"Molecules"},{"key":"3246_CR26","first-page":"5473","volume":"15","author":"S Tu","year":"2018","unstructured":"Tu S, Zhang XL, Wan HF, Xia YQ, Liu ZQ, Yang XH, et al. Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells. Oncol Lett. 2018;15:5473\u201380.","journal-title":"Oncol Lett"},{"key":"3246_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/CM9.0000000000000162","volume":"132","author":"H Li","year":"2019","unstructured":"Li H, Ruan WJ, Liu LQ, Wan HF, Yang XH, Zhu WF, et al. Impact of taurine on the proliferation and apoptosis of human cervical carcinoma cells and its mechanism. Chin Med J (Engl). 2019;132:948\u201356.","journal-title":"Chin Med J (Engl)"},{"key":"3246_CR28","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/molecules29081718","volume":"29","author":"T Latronico","year":"2024","unstructured":"Latronico T, Petraglia T, Sileo C, Bilancia D, Rossano R, Liuzzi GM. Inhibition of MMP-2 and MMP-9 by dietary antioxidants in THP-1 macrophages and Sera from patients with breast Cancer. Molecules. 2024;29:1718.","journal-title":"Molecules"},{"key":"3246_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/bmm-2018-0256","volume":"13","author":"W Dazhi","year":"2019","unstructured":"Dazhi W, Jing D, Chunling R, Mi Z, Zhixuan X. Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer. Biomark Med. 2019;13:95\u2013104.","journal-title":"Biomark Med"},{"key":"3246_CR30","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3892\/mmr.2020.11321","volume":"22","author":"S Baliou","year":"2020","unstructured":"Baliou S, Kyriakopoulos AM, Goulielmaki M, Panayiotidis MI, Spandidos DA, Zoumpourlis V. Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review). Mol Med Rep. 2020;22:2163\u201373.","journal-title":"Mol Med Rep"},{"key":"3246_CR31","doi-asserted-by":"crossref","unstructured":"Han X, Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication. Adv Exp Med Biol. 2019;1155:543\u201353.","DOI":"10.1007\/978-981-13-8023-5_50"},{"issue":"9","key":"3246_CR32","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Yasunaga M, Matsumura Y, Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. Sci Rep. 2014;4:4852.","journal-title":"Cell"},{"key":"3246_CR33","doi-asserted-by":"crossref","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, Ge M, Tian M, Yu J, Jiao A, Wang L, Liu M, Wang P, Guo Z, Zhou Y, Chen S, Yin W, Yi J, Guo H, Han H, Zhang B, Wu K, Fan D, Wang X, Nie Y, Lu Y, Zhao X. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+T\u00a0cells. Cell. 2024;187:2288\u2013304.e27.","DOI":"10.1016\/j.cell.2024.03.011"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03246-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:37:47Z","timestamp":1757306267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03246-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03246-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the ethical principles of the Declaration of Helsinki and received approval from the Ethics Committee of the First Affiliated Hospital of Guangdong Pharmaceutical University (2020, No.29). The patient agrees to participate and signs an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1414"}}